Furthermore, understanding the molecular mechanisms underlying OPN's effects on neuroinflammation and neuroplasticity may reveal novel therapeutic targets for mood disorders and cognitive impairment associated with brain injury. This evidence concerns the gene SPP1 and mood disorder.